Azitra, Inc. (AZTR) — SEC Financial Statements & Analysis

Azitra, Inc. (AZTR) is a pharmaceutical preparations company, incorporated in DE. Azitra, Inc. trades on NYSE as: AZTR. Azitra, Inc. (AZTR)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Azitra, Inc. carries a market cap of $3.24M, a P/E ratio of -0.26x, a P/B ratio of 0.44x, a P/S ratio of 532.65x, an enterprise value of $-3.48M, and an EV/EBITDA multiple of 0.29x. On profitability, it posts an operating margin of -148318.41%, a net margin of -121372.83%, a Return on Equity (ROE) of -256.67%, a Return on Assets (ROA) of -190.69%, and a Return on Invested Capital (ROIC) of -1363.82%. Per share, it reports EPS of $-0.64, diluted EPS of $-0.64, free cash flow per share of $-0.58, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 31.12% year-over-year, and EPS growth of -83.39% year-over-year. On the balance sheet, it maintains a current ratio of 4.86x, a quick ratio of 4.49x, working capital of $5.91M, a debt-to-equity ratio of 0.22x, a debt ratio of 0.18, an interest coverage ratio of -1164.70x, free cash flow of $-11.17M (TTM), and net debt of $-6.73M. Figures sourced from SEC EDGAR.

Market Cap

$3.24M

P/E TTM

-0.26x

EPS TTM

$-0.64

P/B TTM

0.44x

ROE TTM

-256.67%

ROA TTM

-190.69%

Debt To Equity

0.22x

Free Cash Flow TTM

$-11.17M

Net Revenue TTM Growth 1Y

-100.00%

Data as of 2026-06-30 · Source: SEC EDGAR